Endothelial Dysfunction in Dyslipidaemia: Molecular Mechanisms and Clinical Implications

Area of Science:

• Cardiovascular Biology
• Endothelial Cell Biology

Background:

• The endothelium, a monolayer of endothelial cells (ECs), lines blood and lymphatic vessels, regulating crucial functions like vasodilation and lipoprotein metabolism.
• Endothelial dysfunction, characterized by impaired nitric oxide (NO) availability and an imbalance of vasoactive factors, precedes atherosclerosis development and signifies atherosclerotic risk.

Purpose of the Study:

• To summarize the role of the endothelium and endothelial dysfunction in atherogenesis.
• To review historical and current therapeutic approaches for endothelial dysfunction, including antioxidant therapy and statins.

Main Methods:

• Literature review of endothelial cell function, dysfunction markers, and therapeutic interventions.
• Analysis of the impact of various treatments on endothelial function and associated cardiovascular risk factors.

Main Results:

• Endothelial cells synthesize and release key compounds including Nitric Oxide (NO) and Reactive Oxygen Species (ROS).
• Endothelial dysfunction is linked to impaired NO synthesis and an imbalance in endothelial-derived relaxing and contracting factors.
• Antioxidant therapy and statins have shown short-term benefits in improving endothelial function and adhesion molecule expression.

Conclusions:

• Endothelial dysfunction is an early event in atherogenesis and a significant marker of cardiovascular risk.
• Further research into the mechanisms of statins' beneficial effects on the endothelium is warranted for targeted drug development.